Dr. Herbert Loong
banner
herbloongmd.bsky.social
Dr. Herbert Loong
@herbloongmd.bsky.social
Medical Oncologist w/ interests in #lungcancer, #sarcoma & #drugdevelopment | Associate Professor, Department of Clinical Oncology & Deputy Medical Director, Phase 1 Clinical Trials Centre, CUHK
Putting some last minute slides together 😂.

Flight delayed from #HKG to #FRA so not sure whether we can make the transit, but #GütenMorgenAlles and see you in person at Berlin for @myESMO #ESMO25!

#sarcoma #LCSM @ctosociety @apoddc @APCLC_2023
October 17, 2025 at 1:46 PM
The @ascocancer.bsky.social
#InternationalAffairsCommittee #2025-26. An absolute delight and pleasure working with these highly engaged professionals from across the world 🌎 and across oncology disciplines. #BestASCOCommittee
September 6, 2025 at 9:19 AM
It's always a pleasure meeting #colleagues on home turf in #hongkong 🇭🇰 after a long day of clinic. #LCSM @cuhkmedicine.bsky.social
August 31, 2025 at 11:23 AM
Whirlwind 2 days in #Manila at #PSMO
@astra-zeneca.bsky.social 🫁 #lungcancer #preceptorship w/ colleagues & experts including @KSamalaMD #ArthurLui 🇵🇭 together w/ #QuincyChu of @AlbertaUni 🇨🇦. Covered broad topics: #targetedtherapies, #IO, #EGFR and #SCLC. #LCSM
@cuhkmedicine.bsky.social @APCLC_2023
August 31, 2025 at 11:20 AM
🇭🇰🚝✈️🇨🇦🚗🏥=🤩 Looking forward to #returning to #Toronto & my alma mater @uhnresearch.ca #PrincessMargaretCancerCentre for a short visit this weekend! Very honoured and privileged to be able to give #GrandRounds 🎙️

Best way to fight jetlag! See you soon!👋

#LCSM #Sarcoma #CUHKSarcoma #precisiononcology
July 24, 2025 at 12:22 AM
Putting final touches together to my talk😀. Looking forward to welcoming you all to #hongkong 🇭🇰 for #ESMOTATAsia25! Don't be shy - come by and say hi!

#drugdevelopment @cuhkmedicine.bsky.social @apoddc @APCLC_2023
July 15, 2025 at 9:46 AM
Come join us in a couple of hours as we discuss several #abstracts related to #GISTs presented at #ASCO25!

Registration is free! Register here: us02web.zoom.us/webinar/regi...

@liferaftgroup.bsky.social @ctosociety #sarcoma @cuhkmedicine.bsky.social #CUHKSarcoma #PublicEducation
June 19, 2025 at 3:36 PM
After serving on #MembershipCommittee, I look forward to returning to #CommunicationsCommittee
@iaslc.bsky.social w/ #LCSM colleagues from around the World 🌐 to create #effective, #efficient & #robust channels of communications between our society & community. @CUHKMedicine @apoddc @APCLC_2023
June 10, 2025 at 8:03 AM
#Honoured and #humbled to have been awarded #FASCO at @ascocancer.bsky.social #ASCO25. My thanks to my friends and colleagues for your overwhelming support along the way 😊

#sarcoma #LCSM #InternationalAffairsCommittee #drugdevelopment #precisiononcology
June 1, 2025 at 1:36 PM
T-13hrs 59mins before landing in #Chicago for @ascocancer.bsky.social #ASCO25! ✈️ full of oncology colleagues from 🇭🇰🇵🇭 and from 🇦🇺🦘🐨😀.

What’s the combined H-index of this flight? 🧐

Looking fwd to days of #scientificexchanges and #interactivediscussions. Safe travels everyone! See you at McCormick!
May 29, 2025 at 5:19 AM
As @ascocancer.bsky.social #ASCO25 is round the corner, so is the end of my #chair of #InternationalAffairsCommittee.

Tks all my colleagues & friends from around the World 🌍 for continuous support.

Time to pass torch 🔥 to Dr. Monica Malik who will continue to push our global agenda forward!
May 26, 2025 at 11:36 PM
Come join us in #hongkong 🇭🇰 🍜🥟🥡 for the #inaugural @myesmo.bsky.social #ESMOTATAsia25 on July 18-20, 2025! We have assembled a #stellar group of #international #faculties and #experts in #drugdevelopment to help move the field forward. Register today!
May 7, 2025 at 12:25 PM
Thanks my #coinvestigators for opportunity to present data of #D3S_001, a novel #KRASG12C inhibitor in #G12Ci pre-treated #NSCLC at @theaacr.bsky.social #AACR25. Strong & rapid #targetengagement confer superior #efficacy c.f. 1st generation G12Ci.

✔️ORR 30%; DCR 80% in KRASG12Ci pre-treated popn.
April 30, 2025 at 4:53 PM
Better late than never! 🤣 Arrived in #Chicago for @theaacr.bsky.social #AACR25 after 14 hours flight ✈️ and looking forward to the #ClinicalTrials #Minisymposium tomorrow.
April 28, 2025 at 7:28 PM
Wonderful opportunity to #share & #discuss emerging role of #TCellEngagers #BiTEs in Mx of #SCLC 🫁 w/ our Malaysian 🇲🇾 colleagues during #LCS2025.

Small group discussions (esp. over a meal! 😋) are always very interactive for experience sharing.

#LCSM @APCLC_2023 @apoddc @cuhkmedicine.bsky.social
April 28, 2025 at 4:43 AM
📢The @ctosociety #SpringWebinar is taking place in < 72hours! Come join our #international faculty on #EwingSarcoma as we take deep dive into similarities and differences of this "same" disease in #paediatrics and #adults patients!

Register today at: ctos.org/EducationalP...

#CTOSTweeTOS #sarcoma
April 27, 2025 at 6:05 AM
Thank you #LCS2025 in #KualaLumpur 🇲🇾 for hosting an informative & interactive lung cancer meeting! Always pleasure to meet colleagues who are keen to move our 🫁 field forward. #LCSM @apoddc @APCLC_2023

@stephanieplsaw @drdaviddwlee #BeungChulAhn #PJVoon #JenniferLeong @drsanjaypopat.bsky.social
April 26, 2025 at 4:27 PM
@drsanjaypopat.bsky.social speaking on treatment landscape in #NSCLC and #SCLC beyond #immunotherapies in the era of #ADCs 💉at #LCS2025 in #KualaLumpur 🇲🇾. #LCSM #drugdevelopment @voonpeijye @davidlee
April 26, 2025 at 7:07 AM
Heading to #KualaLumpur #Malaysia 🇲🇾 to meet #LCSM friends and colleagues at #LCS2025 🫁. Looking forward to some fruitful discussions and #NasiLemak! 😋 @drdaviddwlee @stephanieplsaw @APCLC_2023 @apoddc
April 25, 2025 at 11:47 AM
Thrilled to have #friend & #collaborator
@KaiKeenShiu of @ucl.ac.uk 🇬🇧 visit us in #hongkong 🇭🇰 these last few days, including a visit & talk specifically
@cuhkmedicine.bsky.social this afternoon.

Good to familiarise myself with updates in #GICancers as well!
@StephenLChan1 @mollylisc #KaOnLam
April 16, 2025 at 7:52 AM
Amazing #friends and #colleagues from around the #world! A fruitful #lungcancer and #culinary trip to #Taipei 🇹🇼. #LCSM
April 13, 2025 at 3:01 PM
Happy to share our recent #ESMOOpen paper on the #safety and #feasibility of #outpatient administration of #tarlatamab as part of the #DeLLphi300 study providing evidence that support less intensive monitoring at initiation of therapy. #LCSM 🫁 #SCLC 😀

doi.org/10.1016/j.es...
April 5, 2025 at 10:12 AM
📢 Pleased to have launched #prospective #PUSH project on #LGFMS and #SEF last month. First #coordinated #multistakeholder #international effort 🌎 utilising this unique platform to study rare cancers 🦀.

Video recording of our launch meeting is available here: push-platform.org/LGFMS_Study....
April 5, 2025 at 1:37 AM
Wonderful crew of #ESMORarecancer25 #YOCasesDiscussion session! Definitely not-so-young oncologists are also welcome.

Great cases discussed and thanks everyone for contributing!

@pawel_sobczuk @DrLizConnolly @Robertasanfili @RobinL_Jones @haileykcarroll and many others. #sarcoma #CTOSTweeTOS
March 22, 2025 at 12:53 PM